|
Model Number B-50000 |
Device Problem
Free or Unrestricted Flow (2945)
|
Patient Problem
Pain (1994)
|
Event Date 10/28/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
Medwatch sent to the fda on 12/07/2016.The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Device labeling addresses the reported events as follows: warnings and precautions: the physiological response of the patient to the presence of the orbera system balloon may vary depending upon the patient's general condition and the level and type of activity.The types and frequency of administration of drugs or diet supplements and the overall diet of the patient may also affect the response.Each patient must be monitored closely during the entire term of treatment in order to detect the development of possible complications.Each patient should be instructed regarding symptoms of deflation, gastrointestinal obstruction, ulceration and other complications which might occur, and should be advised to contact his/her physician immediately upon the onset of such symptoms.Complications - possible complications of the use of the orbera system include: - gastric discomfort, feelings of nausea and vomiting following balloon placement as the digestive system adjusts to the presence of the balloon.- abdominal or back pain, either steady or cyclic.
|
|
Event Description
|
Reported as: a patient had the orbera intragastric balloon placed, and after a period, patient complained about "discomfort and abdominal pain.Doctor requested x-ray exam that confirmed air inside the balloon." the device was removed and replaced.
|
|
Manufacturer Narrative
|
Supplement #1: medwatch sent to fda on 01/25/2017.The device was returned to apollo.A visual examination was performed, and noted the returned device to be discolored, and the shell was blue in appearance.White particles were also noted on the outer surface of the shell, valve patch and valve channel.An opening/hole was noted on the radius of the device.A valve test was performed and the flow of di water was continues and unobstructed.An air leak test was performed and leakage was noted from a single opening on the radius of the shell.The openings were noted to be striated, consistent with damage from a surgical tool.Under microscopic analysis, black particles were observed in the valve channel/hole.
|
|
Manufacturer Narrative
|
Supplement #2 - medwatch sent to the fda on 26-jul-2017.Device evaluation summary: additional testing was performed on the device.The valve was noted to be leaking.The slit valve was removed from the device using a razor blade for testing.Pressure testing of the slit valve was performed, the outside to inside pressure was noted to be 0.19 psi.The inside to outside pressure was noted to be 0.29 psi.The valve was cross-sectioned along the sealing mechanism, and examined microscopically with a magnification between 20x-60x.The surface of sealing mechanism showed typical axial lines parallel to the valve access due to the blade cutting direction during valve manufacturing.The inner edge of the cut appeared to be more defined than the opposite edge, likely a consequence of the valve slitting process.
|
|
Search Alerts/Recalls
|
|
|